Johnson & Johnson: (NYSE: JNJ)

$87.63

0.66 (0.76%)

Volume 9,115,917

May 15 03:59 PM ET

Zacks Rank: 3-Hold

 
 
#3
 
 

Overview Quote

Get Overview Quote for:

Stock Activity

Day Low - High 86.94 - 87.88
52wk Low - High 61.71 - 87.88
Previous Close 86.97
Avg. Volume 9,226,935
Industry LARGE CAP PHARMA
Market Cap 243.26 B
Div - Yield 2.44 - 2.81
Beta 0.55
PE (Forward) 16.07
Current Year Est. 5.41
Quarterly Earnings ESP 0.71%

Premium research

Zacks Rank Short-Term: 1-3 Months

Zacks #1 Rank Strong Buys

3

Zacks Recommendation Long-Term: 6+ Months

All Outperform Rated Stocks

Neutral

Zacks Industry Rank

170 out of 265

Equity Research Report

Updated as of 05/9/2013

PREMIUM

( = Change in last 30 days)

Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial

Key Earnings Data

PE (Forward) 16.07
PEG Ratio 2.59
Current Year Est. 5.41
Current Quarter Estimate 1.40
Most Accurate Estimate 1.41
Earnings ESP 0.71%
Next Earnings Report Date 07-16-2013
EPS Last Year 5.18
Expected Earnings Growth 6.20%

Company Description

Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.

NYSE data is at least 20 minutes delayed.

NASDAQ data is at least 15 minutes delayed.

Interactive Java Charting | Fundamental Charts

Introducing Zacks Whisper Trader

Turn Earnings Surprises into quick profits.

 

JNJ Chart by YCharts

Earnings Estimates

Current Qtr
(06/2013)
Next Qtr
(09/2013)
Current Year
(12/2013)
Next Year
(12/2014)
Average Estimate 1.40 1.33 5.41 5.78
Number of Estimates 10 10 16 13
Low Estimate 1.38 1.32 5.35 5.61
High Estimate 1.43 1.35 5.50 NA
Year Ago EPS 1.30 1.25 5.10 5.41
EPS Growth 8.00% 6.48% 6.13% 6.75%

Average Earnings Estimates for JNJ

EPS Growth for JNJ

Industry Analysis

Name Symbol Previous Close Zacks Rank Zacks Recommendation
JOHNSON & JOHNS JNJ 86.97
ABBOTT LABS ABT 37.05
ABBVIE INC ABBV 45.35
ALLERGAN INC AGN 103.78
ASTRAZENECA PLC AZN 51.19
BRISTOL-MYERS BMY 42.21
GLAXOSMITHKLINE GSK 51.72
LILLY ELI & CO LLY 55.87
MERCK & CO INC MRK 46.65
NOVARTIS AG-ADR NVS 74.59

Sector:Medical>> Industry:LARGE CAP PHARMA

COMPARE TICKER vs. Its Peers

Financials

EPS TTM 5.18
Sales 67,224
Net Income 10,440
Price/Earnings 16.79
Price/Book 3.64
Price/Cash Flow 13.38
Price/Sales 3.55

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.